- Home
- TAK vs DXCM Comparison
TAK vs DXCM Comparison
Compare TAK & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- DXCM
- Stock Information
- Founded
- TAK 1781
- DXCM 1999
- Country
- TAK Japan
- DXCM United States
- Employees
- TAK N/A
- DXCM N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- DXCM Medical/Dental Instruments
- Sector
- TAK Health Care
- DXCM Health Care
- Exchange
- TAK Nasdaq
- DXCM Nasdaq
- Market Cap
- TAK 42.2B
- DXCM 35.7B
- IPO Year
- TAK N/A
- DXCM 2005
- Fundamental
- Price
- TAK $15.04
- DXCM $68.48
- Analyst Decision
- TAK
- DXCM Strong Buy
- Analyst Count
- TAK 0
- DXCM 17
- Target Price
- TAK N/A
- DXCM $99.82
- AVG Volume (30 Days)
- TAK 1.5M
- DXCM 4.6M
- Earning Date
- TAK 05-08-2025
- DXCM 04-24-2025
- Dividend Yield
- TAK 3.39%
- DXCM N/A
- EPS Growth
- TAK 15.39
- DXCM 9.35
- EPS
- TAK 0.83
- DXCM 1.42
- Revenue
- TAK $29,124,927,177.00
- DXCM $4,033,000,000.00
- Revenue This Year
- TAK $8.53
- DXCM $16.49
- Revenue Next Year
- TAK N/A
- DXCM $15.58
- P/E Ratio
- TAK $36.00
- DXCM $48.11
- Revenue Growth
- TAK 9.83
- DXCM 11.34
- 52 Week Low
- TAK $12.58
- DXCM $62.34
- 52 Week High
- TAK $15.22
- DXCM $142.00
- Technical
- Relative Strength Index (RSI)
- TAK 70.24
- DXCM 22.49
- Support Level
- TAK $14.83
- DXCM $69.02
- Resistance Level
- TAK $15.22
- DXCM $72.30
- Average True Range (ATR)
- TAK 0.17
- DXCM 3.03
- MACD
- TAK 0.03
- DXCM -2.20
- Stochastic Oscillator
- TAK 84.84
- DXCM 0.76
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.